Beta-thalassemia major (BTM) is a severe transfusion-dependent disease complicated by secondary hemosiderosis, leading to organ damage in the heart, liver, and endocrine glands. Endocrine disorders are among the most frequent complications, significantly reducing quality of life.
(2025). Hepcidin mRNA and Endocrine Risk in β-Thalassemia. Egyptian Society of Diabetes and Lipidology Journal, 5(2), -. doi: 10.21608/esdlj.2025.456297
MLA
. "Hepcidin mRNA and Endocrine Risk in β-Thalassemia", Egyptian Society of Diabetes and Lipidology Journal, 5, 2, 2025, -. doi: 10.21608/esdlj.2025.456297
HARVARD
(2025). 'Hepcidin mRNA and Endocrine Risk in β-Thalassemia', Egyptian Society of Diabetes and Lipidology Journal, 5(2), pp. -. doi: 10.21608/esdlj.2025.456297
VANCOUVER
Hepcidin mRNA and Endocrine Risk in β-Thalassemia. Egyptian Society of Diabetes and Lipidology Journal, 2025; 5(2): -. doi: 10.21608/esdlj.2025.456297
)
